|
INE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.50472000000068E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.632200E-04 |
| Normal-vs-Stage2 |
1.740280E-03 |
| Normal-vs-Stage3 |
1.92909999996438E-06 |
| Normal-vs-Stage4 |
1.783200E-03 |
| Stage1-vs-Stage2 |
8.337800E-01 |
| Stage1-vs-Stage3 |
1.027180E-01 |
| Stage1-vs-Stage4 |
4.917400E-01 |
| Stage2-vs-Stage3 |
3.157200E-01 |
| Stage2-vs-Stage4 |
7.026000E-01 |
| Stage3-vs-Stage4 |
6.736600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.237400E-04 |
| Normal-vs-AfricanAmerican |
1.239820E-02 |
| Normal-vs-Asian |
8.236700E-03 |
| Caucasian-vs-AfricanAmerican |
7.250400E-01 |
| Caucasian-vs-Asian |
6.162200E-01 |
| AfricanAmerican-vs-Asian |
5.227000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.378300E-04 |
| Normal-vs-Female |
3.92819999994742E-06 |
| Male-vs-Female |
9.066000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.968900E-04 |
| Normal-vs-Age(41-60Yrs) |
7.87960000000476E-05 |
| Normal-vs-Age(61-80Yrs) |
2.364300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.80495999999586E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.674800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.829200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.858000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.233000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.286110E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.210200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.77119996447317E-09 |
| Classical-VS-Follicular |
1.474030E-01 |
| Classical-VS-Other |
4.635800E-01 |
| Classical-VS-Normal |
4.379800E-04 |
| Tall-VS-Follicular |
1.122470E-03 |
| Tall-VS-Other |
5.585800E-02 |
| Tall-VS-Normal |
6.10239969667248E-10 |
| Follicular-VS-Other |
8.257400E-01 |
| Follicular-VS-Normal |
2.175900E-04 |
| Other-VS-Normal |
5.032300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.94729999999366E-05 |
| Normal-vs-N1 |
1.110390E-01 |
| N0-vs-N1 |
1.474610E-01 |
|
|
